Cells involved in aggressive prostate cancer growth to be targeted in the disease’s early stages

A new sub-group of cells that influences prostate cancer recurrence has been identified by researchers at Monash University.

The previously unidentified cells are present in the disease’s early stages, opening up new doors to develop a therapy which targets these cells and prevents the disease from progressing to an aggressive stage.

Prostate cancer is the most common form of cancer in men, claiming more than 3000 Australian lives and affecting up to 20,000 annually.

For advanced cases, the best available treatment involves drugs that deprive the tumour of the male hormones which cause it to grow (androgen-deprivation therapy) . In many cases, the tumour can become resistant to this treatment leaving the patient with both debilitating side-effects and an aggressive new form of the prostate cancer.

The new sub-group of cells identified by Monash researchers is involved in this very treatment resistance. Continue reading “Cells involved in aggressive prostate cancer growth to be targeted in the disease’s early stages”

ACRF awards $8.5 million to 4 world-class cancer research initiatives

Australia’s best scientists have been given a major boost in their fight against cancer, with the announcement of $8.5 million worth of grants from the ACRF to the nation’s finest research institutions.

The Foundation awarded a total of three grants – to $2million grant to The Walter and Eliza Hall Institute (Melbourne), $2.4million to Western Australian Institute for Medical Research and $1.6million to Monash Institute of Medical Research (Melbourne).  This is in addition to the ‘top-up’ grant of $2.5 million the ACRF pledged earlier to The Kinghorn Cancer Centre, a joint facility of the Garvan Institute of Medical Research and St. Vincent’s Hospital in Sydney.

Continue reading “ACRF awards $8.5 million to 4 world-class cancer research initiatives”

2010 ACRF grant recipients

The 2010 ACRF grants – totalling $8.5 million – will fund two new cancer divisions, a scanner for imaging tumour development and state-of-the-art genomic technologies. Since 1987 the Foundation has provided 41 grants totalling almost $71 million to Australian cancer research institutes ($48 million of which has been awarded in the last six years). This year four grants have been awarded to four cutting edge research projects around the country. Continue reading “2010 ACRF grant recipients”

ACRF to announce 2010 grant recipients

With the final review of the shortlisted applicants for Australian Cancer Research Foundation’s (ACRF) multi-million dollar grant program, the Foundation is set to announce the 2010 grant recipients in just one week.

All grant applications received by the Foundation are reviewed by the ACRF’s Medical Research Advisory Committee (MRAC) whose members are scientists of the highest national and global repute.

This leading Australian scientific committee make recommendations to the ACRF Board of Trustees after a rigorous review process. Assessment of applications is made by independent expert assessors, as well as an inspection of sites where grants will be applied to fund laboratories and house equipment.

The ACRF will announce the 2010 grant recipients on Thursday 25 November. Continue reading “ACRF to announce 2010 grant recipients”